What are the Challenges in Using Nanotechnology for Drug Screening?
Despite its potential, there are several challenges associated with the use of nanotechnology in drug screening:
1. Toxicity: The potential toxicity of nanomaterials to biological systems is a significant concern. Comprehensive studies are needed to ensure their safety. 2. Regulatory Issues: The use of nanomaterials in pharmaceuticals is subject to stringent regulatory scrutiny, which can complicate the approval process. 3. Scalability: Producing nanoscale materials and devices in large quantities can be challenging and expensive. 4. Complexity: The integration of nanotechnology into existing drug screening workflows requires specialized knowledge and equipment, which may not be readily available in all research settings.
